Investment Summary |
|
|---|---|
| Date | 2018-04-27 |
| Target | Innovent Biologics |
| Sector | Life Science |
| Sellers(s) |
Milestone Venture Group
Temasek Holdings Eight Roads Capital Group Private Markets |
| Deal Type | IPO |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1997 |
| Size | Small |
| Type | Sector Agnostic |
Milestone Venture Group is a private equity investment firm that focuses on acquiring small to mid market companies. Milestone focuses on investments in the Southwest US in sectors including distribution, manufacturing, service, and value-added processing. Milestone's investment horizon is four to six years. The Firm will not invest in start-ups, pure construction companies, real estate projects, energy exploration or high-tech companies where no revenue-producing product or service line exists. Milestone Venture Group is based in Houston, Texas.
| DEAL STATS | # |
|---|---|
| Overall | 6 of 6 |
| Sector: Life Science M&A | 1 of 1 |
| Type: IPO M&A Deals | 2 of 2 |
| Country: China M&A | 1 of 1 |
| Year: 2018 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-11-29 |
Innovent Biologics
Suzhou, China Innovent Biologics is a biopharmaceutical company in China that develops, manufacture, and commercialize high-quality innovative medicines for the treatment of cancer and other major diseases. Innovent Biologics was founded in 2011 and is based in Suzhou, China. |
Buy | - |
| Category | Sovereign Wealth Fund |
|---|---|
| Founded | 1974 |
| PE ASSETS | 434.0B SGD |
| Size | Mega |
| Type | Sector Agnostic |
Temasek Holdings is a state-owned investment holding company. Temasek is owned by the government of Singapore and invests directly and indirectly in a broad range of assets and sectors. Target sectors include financial services, telecommunications, media, technology, transportation, industrials, life science, consumer, real estate, energy, and resources. Temasek was formed in 1974 and is based in Singapore.
| DEAL STATS | # |
|---|---|
| Overall | 7 of 20 |
| Sector: Life Science M&A | 1 of 3 |
| Type: IPO M&A Deals | 3 of 7 |
| Country: China M&A | 1 of 1 |
| Year: 2018 M&A | 2 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-04-04 |
Mobike Singapore Pte
Singapore, Singapore Mobike Singapore Pte Ltd. is a bike sharing service to fulfil urban short trips conveniently, anytime, anywhere, by combining innovation and today’s IoT (Internet of Things) technology. Mobike is green, reduces congestion and continually strives to improve the quality of city life. Mobike provides an affordable means of shared transportation for convenient short urban trips, while reducing congestion and our city's carbon footprint that improves the quality of city life. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-06-08 |
Ant Group
Hangzhou, China Ant Group is focused on serving small and micro enterprises, as well as consumers. Ant Group is dedicated to building an open ecosystem of Internet thinking and technologies while working with other financial institutions to support the future financial needs of society. Ant Financial Services Group was founded in 2004 and is based in Hangzhou, China. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1969 |
| PE ASSETS | 11.0B USD |
| Size | Mega |
| Type | Sector Focused |
Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.
| DEAL STATS | # |
|---|---|
| Overall | 38 of 124 |
| Sector: Life Science M&A | 26 of 51 |
| Type: IPO M&A Deals | 22 of 52 |
| Country: China M&A | 10 of 19 |
| Year: 2018 M&A | 6 of 12 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-04-19 |
Surface Oncology
Cambridge, Massachusetts, United States Surface Oncology is an immuno-oncology company developing next-generation antibody therapies focused on the tumor microenvironment. Its pipeline includes two wholly-owned programs: SRF388, a Phase 2 program targeting IL-27, and SRF114, a Phase 1 program that selectively depletes regulatory T cells in the tumor microenvironment via targeting CCR8. Surface Oncology was founded in 2014 and is based in Cambridge, Massachusetts. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-05-03 |
Acacia Pharma
Cambridge, United Kingdom Acacia Pharma is a pharmaceutical company specializing in the development of drugs for cancer supportive care. The growth in the cancer supportive care market has been driven by the increasing incidence of cancer, the expansion of effective cancer therapies and the desire to improve both the effectiveness of treatment and the quality of life of cancer patients. Acacia Pharma was founded in 2007 and is based in Cambridge, United Kingdom. |
Sell | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1992 |
| PE ASSETS | 5.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
Capital Group Private Markets is the direct investment arm of asset manager Capital Group. Capital Group Private Markets pursues expansion stage company investments in emerging markets with a focus on companies that locally dominate their respective markets. Capital Group Private Markets generally seeks minority positions, but will consider select control situations as well. Capital Group Private Markets was formed in 1992 and is headquartered in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 10 |
| Sector: Life Science M&A | 1 of 2 |
| Type: IPO M&A Deals | 2 of 4 |
| Country: China M&A | 1 of 1 |
| Year: 2018 M&A | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-12-14 |
Zamp
São Paulo, Brazil Zamp develops, operates, and franchises restaurants under the Burger King and POPEYES names in Brazil. Zamp was founded in 2011 and is based in São Paulo, Brazil. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-06-01 |
Jinxin
Chengdu, China Jinxin Maternity is a provider of obstetrics, gynecology, neonatal and pediatric care, and in the case of one hospital, psychiatric specialty care. It operates four hospitals based in Chengdu in the Southwest Sichuan province of China. |
Buy | - |
